Exact Sciences (EXAS)
49.15
+1.62 +3.41%
NASDAQ
Oct 20, 20:00
Delayed 2m
USD
View All Key Stats
EXAS Key Stats
| Income Statement | |
| Revenue (TTM) | 169.36M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.28 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -140.71M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.79% |
| Profit Margin (Quarterly) | -53.41% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 5.854B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 31.74 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 10.83 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0087 |
| Free Cash Flow (Quarterly) | -46.22M |
| Return on Equity (TTM) | -39.15% |
View All EXAS News
EXAS News
-
WireHeadlineTime (ET)
-
Yahoo10/18 09:20
-
Yahoo10/17 08:01
-
Yahoo10/16 09:41
-
Yahoo10/13 07:16
-
Yahoo10/11 08:52
-
PR Newswire10/10 06:00
-
Yahoo10/09 08:04
-
Yahoo10/06 05:00
-
Yahoo10/03 15:44
-
SA Breaking News10/03 08:13
View All Events
EXAS Events
| Date | Type | Description |
|---|---|---|
| 07/27/2018 | Misc | Exact Sciences Corp Annual General Meeting in 2017 |
| 07/25/2018 | Misc | Exact Sciences Corp Second Quarter Earnings Conference Call in 2018 |
| 07/25/2018 | Earnings | Exact Sciences Corp Second Quarter Earnings Results in 2018 |
| 04/27/2018 | Misc | Exact Sciences Corp First Quarter Earnings Conference Call in 2018 |
| 04/27/2018 | Earnings | Exact Sciences Corp First Quarter Earnings Results in 2018 |
| 02/21/2018 | Misc | Exact Sciences Corp Fourth Quarter Earnings Conference Call in 2017 |
| 02/21/2018 | Earnings | Exact Sciences Corp Fourth Quarter Earnings Results in 2017 |
| 10/31/2017 17:00 EDT | Misc | Exact Sciences Corp Third Quarter Earnings Conference Call in 2017 |
| 10/31/2017 | Earnings | Exact Sciences Corp Third Quarter Earnings in 2017 Release |
| 07/27/2017 | Misc | Exact Sciences Corp Annual General Meeting in 2016 |
EXAS Fundamentals
Income Statement View Statement
EXAS Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
EXAS One Page Reports
- One Page Report Download
EXAS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 49.15 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.exactsciences.com
- Investor Relations URL: http://investor.exactsciences.com/investor-relations/default.aspx
- HQ State/Province: Wisconsin
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Oct. 31, 2017
- Last Earnings Release: Jul. 25, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
EXAS Comparables
EditEXAS Excel Add-In Codes
- Name: =YCI("EXAS","name")
- Description: =YCI("EXAS","description")
- Sector: =YCI("EXAS","sector")
- Industry: =YCI("EXAS","industry")
- Est. Current Fiscal Year End: =YCI("EXAS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other EXAS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EXAS Tweets Stocktwits
Advertisement
